Revision history of "Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis" (Q42937842)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

14 September 2023

  • curprev 07:1007:10, 14 September 2023 KrBot talk contribs 39,663 bytes −1 Set a claim value: title (P1476): Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis undo
  • curprev 07:1007:10, 14 September 2023 KrBot talk contribs 39,664 bytes −1 Changed Dutch label: Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis undo (restore)
  • curprev 07:1007:10, 14 September 2023 KrBot talk contribs 39,665 bytes −1 Changed English label: Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis undo (restore)

3 June 2023

2 March 2022

25 February 2022

27 February 2020

8 January 2019

3 January 2019

14 December 2017

11 November 2017